Risks and implications of multiple actionable pathogenic germline variants discovered by panel-based cancer predisposition testing. This is an ASCO Meeting Abstract from the 2023 ASCO Gastrointestinal ...
WALTHAM, Mass.--(BUSINESS WIRE)--Echosens, a high-technology company offering the FibroScan family of products, announces its partnership with Gastrologix to provide independent GI practices in its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results